MBCI OTC
MabCure Inc.
1W: +0.0%
1M: -80.0%
3M: -93.3%
YTD: -80.0%
1Y: -80.0%
3Y: -99.6%
5Y: -98.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.000500000024
Volume100
Avg Volume1,001
Beta7.88
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJehu Hand
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2007-12-05
Websitemercantilebank.com
21 Sparrow Circle
White Plains, NY 10605
US
White Plains, NY 10605
US
845 591 3144
About MabCure Inc.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Berdugo Gad | A-Award | 200,000 | $0.50 | 2011-05-19 |
| Berdugo Gad | 120,000 | $0.45 | 2010-11-29 | |
| KATZ STEVEN | 0 | — | 2008-07-07 |